Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Precision Treatment of Luminal Advanced Breast Cancer Based on Molecular Subtyping

NCT04355858 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT04355858
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04355858 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Precision Treatment of Luminal Advanced Breast Cancer Based on Molecular Subtyping
Lead sponsor
Fudan University
Phase
Phase 2
Overall status
Unknown status
Start date
May 1, 2020
Completion date
April 1, 2025
Enrollment
319 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, metastatic cancer